| Firm |
Analyst |
| Auriga USA
|
Gene Mannheimer |
| Bank of America Merrill Lynch
|
Robert Willoughby, Fu Muma |
| Barclays Capital
|
Larry Marsh |
| Citi
|
Charles Boorady, Garen Sarafian |
| Deutsche Bank
|
Michael Cherny, Ross Muken |
| First Analysis Corp.
|
Frank Sparacino |
| Jefferies & Co.
|
Richard Close |
| JMP Securities
|
Constantine Davides |
| Madison Williams
|
James Kumpel |
| Morgan Keegan
|
Jamie Stockton |
| Oppenheimer & Co.
|
Charles Rhyee |
| Piper Jaffray
|
Sean Wieland |
| Raymond James & Associates
|
Sandy Draper, Jake Hausman |
| Robert W. Baird & Co.
|
Eric Coldwell, Jeff Elliott |
| ThinkEquity
|
Glenn Garmont |
| Thomas Weisel Partners
|
Steve Halper, Topher Orr |
| UBS Securities
|
Don Hooker |
| Wells Fargo Securities
|
Greg Bolan, Eric Hebert |
| William Blair & Co.
|
Corey Tobin, Jeremy Lopez |
MedAssets, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding MedAssets, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MedAssets, Inc. or its management. MedAssets, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.